Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease

149Citations
Citations of this article
148Readers
Mendeley users who have this article in their library.

Abstract

Parkinson’s disease (PD) is a chronic, progressive, and the second most common form of neurodegenerative disorders. In order to explore novel agents for the treatment of PD, in the current study, we have evaluated the neuroprotective efficacy of ferulic acid (FA) using rotenone (ROT)-induced rat model of PD. ROT was administered 2.5 mg/kg body weight to male Wistar rats for 4 weeks to induce the PD. Since PD is progressive and chronic in nature, the paradigm for evaluating FA was based on chronic administration for 4 weeks at the dose of 50 mg/kg, 30 minutes prior to ROT administration. ROT administration caused significant reduction in endogenous antioxidants such as superoxide dismutase, catalase, and glutathione. ROT challenge-induced lipid peroxidation evidenced by increased malondialdehyde following perturbation of antioxidant defense. Apart from oxidative stress, ROT also activated proinflammatory cytokines and enhanced inflammatory mediators such as cyclooxygenase-2 and inducible nitric oxide synthase. The immunofluorescence analysis revealed a significant increase in the number of activated microglia and astrocytes accompanied by a significant loss of dopamine (DA) neurons in the substantia nigra pars compacta area upon ROT injection. However, treatment with FA rescued DA neurons in substantia nigra pars compacta area and nerve terminals in the striatum from the ROT insult. FA treatment also restored antioxidant enzymes, prevented depletion of glutathione, and inhibited lipid peroxidation. Following treatment with FA, the inflammatory mediators such as cyclooxygenase-2 and inducible nitric oxide synthase and proinflammatory cytokines were also reduced. Further, the results were supported by a remarkable reduction of Iba-1 and GFAP hyperactivity clearly suggests attenuation of microglial and astrocytic activation. Results of our study suggest that FA has promising neuroprotective effect against degenerative changes in PD, and the protective effects are mediated through its antioxidant and anti-inflammatory properties.

References Powered by Scopus

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

3196Citations
N/AReaders
Get full text

α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies

2681Citations
N/AReaders
Get full text

Incidence of Parkinson's disease: Variation by age, gender, and race/ethnicity

1331Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The potential use of plant natural products and plant extracts with antioxidant properties for the prevention/treatment of neurodegenerative diseases: In vitro, in vivo and clinical trials

214Citations
N/AReaders
Get full text

The neuroprotective effects of phenolic acids: Molecular mechanism of action

189Citations
N/AReaders
Get full text

Ferulic acid inhibits neuro-inflammation in mice exposed to chronic unpredictable mild stress

151Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ojha, S., Javed, H., Azimullah, S., Khair, S. B. A., & Haque, M. E. (2015). Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease. Drug Design, Development and Therapy, 9, 5499–5510. https://doi.org/10.2147/DDDT.S90616

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 51

71%

Researcher 12

17%

Professor / Associate Prof. 5

7%

Lecturer / Post doc 4

6%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 18

30%

Biochemistry, Genetics and Molecular Bi... 18

30%

Neuroscience 14

23%

Medicine and Dentistry 10

17%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 26

Save time finding and organizing research with Mendeley

Sign up for free